Inside the mind

ABYA Genomics has been nominated for the Global Startup Awards in the category of Best AI-Enabled Startup. We’re proud to see our efforts toward making our AI platform more accessible to researchers and healthcare innovators worldwide being recognized on a global stage.

Tim Szalay

August 26, 2025

Testing our custom ABYA Viewer on a 2002 Macintosh with 4GB of RAM, and the results were remarkable. Despite the hardware’s limitations, the tool successfully loaded large FASTA files, searched for DNA patterns, and performed calculations with impressive speed.

Tim Szalay

February 5, 2025

Exploring early stage prediction of secondary protein structures using machine learning. The project involves analyzing PDB protein files and identifying meaningful correlations within structural data under limited computational resources. The first model has been successfully implemented.

Tim Szalay

February 4, 2025

Documenting our research sessions and analyses on platforms like YouTube to promote transparency and share an authentic behind the scenes view of our work.

Tim Szalay

February 5, 2025

They are engineered networks of genes and regulatory elements like promoters, enhancers designed to control biological processes in a programmable way, similar to how electronic circuits works. They enable precise control over gene expression and cellular behavior, which is essential for developing targeted therapies for various conditions. These circuits allow us to program cells to respond dynamically to specific triggers, such as inflammation markers.

Tim Szalay

January 4, 2025

Genomics tools such as synteny block detection and genomic dot plots enable us to visualise conserved and divergent genome segments, including structural variants like inversions, deletions and translocations . In the gene therapy, they help identify genomic regions of interest which can then be further analysed in silico.

Tim Szalay

January 8, 2025

Lifelong condition that affects children, causing joint pain, disability, and emotional strain on families. While there’s progress in understanding the disease, its course remains unpredictable. New research is focusing on how genetic factors can predict treatment success and help doctors personalize care for children.

Tim Szalay

December 30, 2024

Autoimmune diseases have challenged us with their complexity and the limitations of traditional treatments. But the game is changing. Gene editing technologies like CRISPR-Cas9 are opening up unprecedented possibilities. By precisely targeting the genetic factors underlying autoimmune responses, we can do more than just manage symptoms.

Tim Szalay

October 31, 2024

Starting with the Patient’s Own Cells, Reprogramming into Stem Cells, Gene Editing with CRISPR/Cas9, Differentiation into Targeted Cell Types, Transplanting the Corrected Cells.

Tim Szalay

October 29, 2024